Precision Medicine at the University of Alabama at Birmingham: Laying the Foundational Processes Through Implementation of Genotype-Guided Antiplatelet Therapy.

Autor: Harada, S, Zhou, Y, Duncan, S, Armstead, AR, Coshatt, GM, Dillon, C, Brott, BC, Willig, J, Alsip, JA, Hillegass, WB, Limdi, NA

Publikováno v: Clinical Pharmacology & Therapeutics; Sep2017, Vol. 102 Issue 3, p493-501, 9p

Clinical and cost-effectiveness of clopidogrel resistance genotype testing after ischaemic stroke or transient ischaemic attack: a systematic review and economic model.

Autor: Carroll, Joe, Lopez Manzano, Catalina, Tomlinson, Eve, Sadek, Ayman, Cooper, Chris, Jones, Hayley E, Rowsell, Lorraine, Knight, John, Mumford, Andrew, Palmer, Rachel, Hollingworth, William, Welton, Nicky J., Whiting, Penny

Publikováno v: Health Technology Assessment; 9/12/2024, Vol. 28 Issue 56/57, p1-194, 194p

Cost-effectiveness of a Pharmacogenomic Test for Stratified Isoniazid Dosing in Treatment of Active Tuberculosis.

Autor: Rens, Neil E, Groot, Carin A Uyl-de, Goldhaber-Fiebert, Jeremy D, Croda, Julio, Andrews, Jason R

Publikováno v: Clinical Infectious Diseases; 12/15/2020, Vol. 71 Issue 12, p3136-3143, 8p

Comparison of Two Point-of-Care CYP2C19 Genotyping Assays for Genotype-Guided Antiplatelet Therapy.

Autor: Yaolin Zhou, Armstead, Alicia R., Coshatt, Gina M., A. Limdi, Nita, Shuko Harada

Publikováno v: Annals of Clinical & Laboratory Science; Nov/Dec2017, Vol. 47 Issue 6, p738-743, 6p

Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world data.

Autor: Limdi NA; Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA. nlimdi@uabmc.edu., Cavallari LH; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, Gainesville, FL, USA., Lee CR; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Hillegass WB; Departments of Data Science and Medicine, University of Mississippi Medical Center, Jackson, MS, USA., Holmes AM; Indiana University-Purdue University Indianapolis, Indianapolis, IN, USA., Skaar TC; Indiana University, Indianapolis, IN, USA., Pisu M; Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Dillon C; Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA., Beitelshees AL; Department of Medicine and Program for Personalized and Genomic Medicine, University of Maryland, Baltimore, MD, USA., Empey PE; Department of Pharmacy and Therapeutics, Center for Clinical Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, Pittsburgh, PA, USA., Duarte JD; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, Gainesville, FL, USA., Diaby V; Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL, USA., Gong Y; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, Gainesville, FL, USA., Johnson JA; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, Gainesville, FL, USA., Graves J; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA., Garbett S; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA., Zhou Z; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA., Peterson JF; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.

Publikováno v: The pharmacogenomics journal [Pharmacogenomics J] 2020 Oct; Vol. 20 (5), pp. 724-735. Date of Electronic Publication: 2020 Feb 11.